The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II trial of AZD1775 plus carboplatin-paclitaxel in squamous cell lung cancer (SqCLC).
 
Bruna Pellini
Employment - H. Lee Moffitt Cancer Center and Research Institute
Honoraria - AstraZeneca; Foundation Medicine; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb/Roche; Gilead Sciences; Illumina; Merus; Regeneron
Research Funding - Bristol Myers Squibb Foundation (Inst); Bristol-Myers Squibb; Moffitt Cancer Center (Inst); National Cancer Institute (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche
 
Jiannong Li
No Relationships to Disclose
 
Michael J Schell
No Relationships to Disclose
 
Michael Melendez
No Relationships to Disclose
 
Tawee Tanvetyanon
No Relationships to Disclose
 
Ben C. Creelan
Consulting or Advisory Role - Achilles Therapeutics plc; AstraZeneca; ER Squibb & Sons, LLC; G1 Therapeutics, Inc; Iovance Biotherapeutics Inc; MJH Healthcare Holdings, LLC; Regeneron
Speakers' Bureau - AstraZeneca; Roche
Research Funding - Cancer Research Institute (Inst); Clinigen Group (Inst); E. R. Squibb & Sons, LLC (Inst); Turnstone Biologics Corp (Inst)
Patents, Royalties, Other Intellectual Property - Patent WO2020263919A1 pending; Patent WO2021163695A2 pending
Travel, Accommodations, Expenses - American Association for Cancer Research; AstraZeneca; ESMO; G1 Therapeutics, Inc; Regeneron; Roche; Society for the Immunotherapy of Cancer
Other Relationship - OmniHealth Media
 
Alberto Chiappori
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Ailleron; Amgen; Daiichi Sankyo/Lilly; G1 Therapeutics; Jazz Pharmaceuticals; Merus; Mirati Therapeutics; Sanofi/Regeneron
Speakers' Bureau - Amgen; Blueprint Medicines; Genentech; Takeda
Research Funding - AstraZeneca; Bristol-Myers Squibb; Jazz Pharmaceuticals
Travel, Accommodations, Expenses - Amgen; Takeda
 
Andreas Nicholas Saltos
Honoraria - MJH Life Sciences; MJH Life Sciences (I)
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Lilly; Zymeworks
Research Funding - AstraZeneca (Inst); BioAtla (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Genmab (Inst); Janssen (Inst); Lilly (Inst); Memgen (Inst); Mersana (Inst); Novartis (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Dava Oncology
 
Eric B. Haura
Consulting or Advisory Role - Kanaph Therapeutics; ORI Capital; Revolution Medicines
Research Funding - AstraZeneca (Inst); Genentech (Inst); Janssen (Inst); Revolution Medicines (Inst); Spectrum Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Protein-Protein Interactions as Biomarkers Patent
 
Michael Rahman Shafique
Consulting or Advisory Role - Jazz Pharmaceuticals
Research Funding - Daiichi Sankyo/Lilly; Genentech (Inst); Pfizer (Inst); Vaccinex (Inst)
 
Trevor Rose
No Relationships to Disclose
 
Farah Khalil
Honoraria - AstraZeneca; GlaxoSmithKline; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Roche; Sanofi
Travel, Accommodations, Expenses - Roche
 
Stephanee Smikker
Employment - Moffitt Cancer Center
Consulting or Advisory Role - Catalyst Pharmaceuticals; Janssen; Takeda
Speakers' Bureau - Pfizer
Travel, Accommodations, Expenses - Catalyst Pharmaceuticals; Pfizer
 
Sam Vafadar
Honoraria - Cardinal Health; Guardant Health; Pfizer
Consulting or Advisory Role - Takeda
Speakers' Bureau - G1 Therapeutics
Travel, Accommodations, Expenses - Cardinal Health
 
Ashley Sansil
Employment - Moffitt Cancer Center; Moffitt Cancer Center (I); Moffitt Cancer Center (I); Moffitt Cancer Center (I); Moffitt Cancer Center (I)
 
Jessica Wermuth
No Relationships to Disclose
 
Milijana Ugrenovic-Petrovic
Employment - Moffitt Cancer Center
 
Alvaro N.A. Monteiro
No Relationships to Disclose
 
Uwe Rix
Patents, Royalties, Other Intellectual Property - Pending patent application: Ligandable target discovery by using fully functionalized fragment-like probes and chemical proteomics, U.S. Provisional Patent Application (Inst)
 
Jhanelle E. Gray
Honoraria - AstraZeneca; Daiichi Sankyo, Inc; EMD Serono/Merck; Flatiron Health; Gilead Sciences; Gilead Sciences; IDEOlogy Health; Janssen Scientific Affairs; Jazz Pharmaceuticals; Merck; Merck; OncoCyte; Pfizer; Regeneron; Spectrum ODAC; Triptych Health Partners
Consulting or Advisory Role - Abbvie; AstraZeneca; Daiichi Sankyo/UCB Japan; Flatiron Health; Gilead Sciences; Gilead Sciences; IDEOlogy Health; Jazz Pharmaceuticals; Merck; Merck; Pfizer; Regeneron; Spectrum Pharmaceuticals; Triptych Health Partners
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); G1 Therapeutics (Inst); Genentech (Inst); Gilead Services (Inst); Lilly (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Novartis (Inst); Panbela Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - Abbvie; OncoCyte; Spectrum Pharmaceuticals